MedPath

Swedish Orphan Biovitrum International AB

🇸🇪Sweden
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.swedishorphan.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

6

NMPA:5
EMA:1

Drug Approvals

Nitisinone Capsules

Product Name
尼替西农胶囊
Approval Number
国药准字HJ20233127
Approval Date
Feb 14, 2023
NMPA

Nitisinone Capsules

Product Name
尼替西农胶囊
Approval Number
国药准字HJ20233130
Approval Date
Feb 14, 2023
NMPA

Nitisinone Oral Suspension

Product Name
尼替西农口服混悬液
Approval Number
国药准字HJ20233126
Approval Date
Feb 14, 2023
NMPA

Nitisinone Capsules

Product Name
尼替西农胶囊
Approval Number
国药准字HJ20233129
Approval Date
Feb 14, 2023
NMPA

Nitisinone Capsules

Product Name
尼替西农胶囊
Approval Number
国药准字HJ20233128
Approval Date
Feb 14, 2023
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.